Clinical trial
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
NCT03193541 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
- Lead sponsor
- Cedars-Sinai Medical Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 30, 2016
- Completion date
- February 28, 2029
- Enrollment
- 900 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer